跳至主要内容
临床试验/RBR-37yq8r6
RBR-37yq8r6招募中3 期

Effect of Buspirone Hydrochloride on the frequency of Bruxism as a somatic manifestation of Anxiety: randomized double-blind placebo-controlled clinical trial

niversidade Federal do Paraná0 个研究点开始时间: 2022年5月24日最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Intervention

入排标准

年龄范围
18Y 至 0(—)

入选标准

  • Both sexes; Older than 18 years; Diagnosis of probable sleep bruxism and definite awake bruxism

排除标准

  • Under 18 years old; Epilepsy and seizure; Acute intoxication and/or chronic use of alcohol, hypnotics, analgesics, or antipsychotic drugs; Smokers; Consumption of more than three cups of coffee per day; Severe kidney and liver failure;
  • Severe neurological or psychiatric disorders; History of chronic musculoskeletal pain; Previous diagnosis or signs and symptoms of chronic TMD and sleep disorders (snoring, sleep apnea, and periodic limb movement); Use of prescription drugs or drugs with possible effects on sleep or changes in motor behavior or drug interactions with buspirone hydrochloride; Gastroesophageal reflux; Enlarged tonsils; BMI > 30; Allergy to electrode gel; Currently undergoing medical or dental treatment; Pregnant women; Users of pacemaker or implanted defibrillator; Loss of more than two posterior teeth, except third molars; Users of complete dentures, removable partial dentures and orthodontic appliances; Skeletal Class II

研究者

发起方
niversidade Federal do Paraná

相似试验